Global Shaper 2012: PB&B, reverse facial aging naturally
29.11.2017
This summer we asked you to vote for your favorite of our supported startups from the past 10 years: those that you felt had the power to change the world. We announced our Global Shapers at our 10 year anniversary event on 29th November and will update you with them on our website throughout December.
 PB&B
|
 |
REVERSE FACIAL AGING NATURALLY
With increasingly aged populations, more and more people are striving to retain youthful beauty and an ageless appearance. In 2016 alone, over 19 million facial anti-aging injections were conducted. It is no wonder that the global market for professional aesthetic products is estimated to continue its double-digit growth,from $8.4bn in 2016 to reach $14bn by 2021. This represents a huge opportunity for the founders of PB&B, who have always been fascinated by aesthetics.
FAT: THE FUTURE OF NATURAL AESTHETICS AND PLASTIC SURGERY
With age, facial fat tissues lose volume, an inevitable process which causes sagging and wrinkles. The Lausanne based startup PB&B set out to reverse this process thanks to a facial rejuvenating injection solution using biodegradable microspheres. These microspheres are loaded with natural lipids (oleic acid, which is naturally present in the body) and then injected into facial fat tissues to naturally replenish lost volume. The technique developed by PB&B can actually achieve the very good looking results of fat transfer (a technique where fat is taken from the body and re-injected into a different area), but without having to take and use any of the patient’s own fat. PB&B’s solution also provides longer lasting results, up to 20 months, compared to other dermal filling techniques such as hyaluronic acid. Following successful R&D tests of its facial injection solution, PB&B will soon be able to expand its development pipeline with body shaping injections. Their aim is to pioneer plastic surgery towards a natural and minimally invasive technique replacing fat transfer, silicone implants or surgery. Many aesthetics and plastic surgery professionals worldwide have already expressed their interest in PB&B’s innovative solution.
GREAT MOMENTUM FROM IDEA TO CLINICAL TESTING
Formed at EPF Lausanne in 2013, PB&B collaborated with scientists, universities, plastic surgeons and hospitals such as the University Hospital of Geneva (HUG) to test and optimize its novel rejuvenating technology. Work has been steady in the past few years, and so has momentum: in 2017, a seasoned clinical trials director joined PB&B’s three co-founders. The company was also able to scale-up production in the US and win a strategic Chinese investor and partner to accelerate market entry in China. In total, PB&B has raised CHF 4m to date andis now looking for additional funds for clinical testing, which will start in 2018, and the development of its product pipeline.
PB&B’s idea was also backed really early on by Venture Kick, among others: “PB&B received the support of Venture Kick in a domain where no one had ever stepped before” explains CEO Anthony Aho. “The program gave us the momentum to turn an idea perceived as impossible into an ambitious company attracting top tier international scientists, doctors and investors”. If everything goes as planned, PB&B could well make a difference in a market worth billions of dollars globally.
See what people are saying on Twitter using the hashtags #10YVentureKick for our anniversary and #VentureKickGS for our Global Shapers
With increasingly aged populations, more and more people are striving to retain youthful beauty and an ageless appearance. In 2016 alone, over 19 million facial anti-aging injections were conducted. It is no wonder that the global market for professional aesthetic products is estimated to continue its double-digit growth,from $8.4bn in 2016 to reach $14bn by 2021. This represents a huge opportunity for the founders of PB&B, who have always been fascinated by aesthetics.
FAT: THE FUTURE OF NATURAL AESTHETICS AND PLASTIC SURGERY
With age, facial fat tissues lose volume, an inevitable process which causes sagging and wrinkles. The Lausanne based startup PB&B set out to reverse this process thanks to a facial rejuvenating injection solution using biodegradable microspheres. These microspheres are loaded with natural lipids (oleic acid, which is naturally present in the body) and then injected into facial fat tissues to naturally replenish lost volume. The technique developed by PB&B can actually achieve the very good looking results of fat transfer (a technique where fat is taken from the body and re-injected into a different area), but without having to take and use any of the patient’s own fat. PB&B’s solution also provides longer lasting results, up to 20 months, compared to other dermal filling techniques such as hyaluronic acid. Following successful R&D tests of its facial injection solution, PB&B will soon be able to expand its development pipeline with body shaping injections. Their aim is to pioneer plastic surgery towards a natural and minimally invasive technique replacing fat transfer, silicone implants or surgery. Many aesthetics and plastic surgery professionals worldwide have already expressed their interest in PB&B’s innovative solution.
GREAT MOMENTUM FROM IDEA TO CLINICAL TESTING
Formed at EPF Lausanne in 2013, PB&B collaborated with scientists, universities, plastic surgeons and hospitals such as the University Hospital of Geneva (HUG) to test and optimize its novel rejuvenating technology. Work has been steady in the past few years, and so has momentum: in 2017, a seasoned clinical trials director joined PB&B’s three co-founders. The company was also able to scale-up production in the US and win a strategic Chinese investor and partner to accelerate market entry in China. In total, PB&B has raised CHF 4m to date andis now looking for additional funds for clinical testing, which will start in 2018, and the development of its product pipeline.
PB&B’s idea was also backed really early on by Venture Kick, among others: “PB&B received the support of Venture Kick in a domain where no one had ever stepped before” explains CEO Anthony Aho. “The program gave us the momentum to turn an idea perceived as impossible into an ambitious company attracting top tier international scientists, doctors and investors”. If everything goes as planned, PB&B could well make a difference in a market worth billions of dollars globally.
See what people are saying on Twitter using the hashtags #10YVentureKick for our anniversary and #VentureKickGS for our Global Shapers